SREBF1 and acute pancreatitis: Researchers found that disruptions in lipid metabolism through pathways such as PI3K/AKT/mTOR/SREBP1 have been shown to aggravate metabolic inflammation, similar to what may occur in severe acute pancreatitis (Chu et al., 2022).